Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00108420 · ClinicalTrials.gov registry record · Phase 4
Prazosin Treatment for Combat Trauma PTSD (Post-Traumatic Stress Disorder) Nightmares and Sleep Disturbance
A Phase 4 study of Stress Disorder, Post Traumatic, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 4
- Development phase
- 1
- Study location
NCT00108420 is a Phase 4 study of Stress Disorder, Post Traumatic that has completed, run by US Department of Veterans Affairs. The trial reports 1 study location across 1 state.
The verdict
NCT00108420, a Phase 4 study of Stress Disorder, Post Traumatic, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1
- Study location
Study Summary
The purpose of this study is to determine whether prazosin will reduce the incidence of nightmares, sleep disturbance, and overall symptoms in combat trauma-exposed individuals with PTSD.
Conditions Studied
Interventions
- DRUG Prazosin
Study Locations (1)
Washington
- VA Puget Sound Health Care System - Seattle
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-10 |
| Est. Completion | 2007-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00108420
The ClinicalTrials.gov registry entry for NCT00108420 describes a study currently listed as completed, categorized as Phase 4. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Stress Disorder, Post Traumatic appearing as the primary indexed condition, and to 1 intervention - of which Prazosin is the first listed.
NCT00108420 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT00108420 about?
NCT00108420 is a clinical study titled "Prazosin Treatment for Combat Trauma PTSD (Post-Traumatic Stress Disorder) Nightmares and Sleep Disturbance". The purpose of this study is to determine whether prazosin will reduce the incidence of nightmares, sleep disturbance, and overall symptoms in combat trauma-exposed individuals with PTSD.
What is the current status of trial NCT00108420?
This trial is currently completed. It is a Phase 4 study. The study started on 2003-10. Estimated completion is 2007-03.
What conditions does trial NCT00108420 study?
This clinical trial studies the following conditions: Stress Disorder, Post Traumatic.
What interventions are being tested in trial NCT00108420?
The interventions under investigation include: Prazosin (DRUG).
Who is sponsoring clinical trial NCT00108420?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00108420 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress Disorder, Post Traumatic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
EEG-based Personalized Transcranial Magnetic Stimulation (eTMS) to Treat Post-Traumatic Stress Disorder
RECRUITING · NA
-
Acceptability and Feasibility of Work-Oriented Social-Cognitive Skills Training for Veterans With Serious Mental Illness
RECRUITING · NA
-
Integrated Cognitive Behavioral Therapy (ICBT) for Posttraumatic Stress Disorder (PTSD) and Substance Use Disorders
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.